HYDROXYLATED AND METHOXYLATED CYCLOPENTA[B]PYRIMIDINES AS PROTEIN KINASE INHIBITORS

摘要

FIELD: medicine, pharmaceutics.SUBSTANCE: present invention refers to new compounds of general formula(I), (the radical values are presented in the patent claim) including their split enantiomers, split diastereomers, solvates and pharmaceutically acceptable salts. What is also described is a method for preparing new compounds, a pharmaceutical composition containing them.EFFECT: use of the compounds as protein kinase inhibitors and a method of treating cancer.113 cl, 49 ex, 1 tbl